Short Sellers Back Off Major Biotechs
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Gilead shares made a slight gain early on Monday after the firm announced that there would be a big change at the top, in terms of its senior management. Not to mention,…
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.
The top analyst upgrades, downgrades and other research calls from Friday included GoldCorp, Gilead, GrubHub, Hilton Worldwide, KKR, Raymond James and Western Digital.
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
There is one fairly new effort for drug companies to mitigate the threat of generic drugs and for biotech companies to mitigate the threat of biosimilars. They can just launch their own.…
Jefferies highlights the firm's top growth stocks to buy each week, and recently four top biotech stocks made the cut. They all make good sense now, and all have outstanding upside potential.